Clinical value and mechanism of CDKN2A in clear cell renal cell carcinoma
{{output}}
Background: Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer, with its incidence increasing annually. This study aims to investigate the role of the Cyclin-Dependent Kinase Inhibitor 2 A (CDKN2A) i... ...